CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Leverage Ratio

OXGN's quarterly Leverage Ratio and Total Liabilities, Equity growth




OXGN Leverage Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity Change 181.28 % 25955.92 % 3041.58 % - -
Y / Y Total Liabilities Change 302.11 % 759.59 % 373.35 % 87.61 % 79.24 %
Leverage Ratio MRQ 0.52 0.56 0.4 0.56 0.36
Overall Ranking # # # # #
Seq. Equity Change 4.54 % -10.59 % 252.09 % -14.53 % 9583.62 %
Seq. Total Liabilities Change -3.16 % 25.08 % 152.12 % 31.67 % 107.03 %



Leverage Ratio second quarter 2020 Comment
Due to repayements of liabilities of -3.16% Mateon Therapeutics Inc improved Leverage Ratio in second quarter 2020 to 0.52, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2020, 103 other companies have achieved lower Leverage Ratio than Mateon Therapeutics Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are OXGN Customers?
Leverage Ratio second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 104
Healthcare Sector # 339
Overall Market # 901


Leverage Ratio Statistics
High Average Low
17.02 0.83 0.02
(Sep 30 2018)   (Mar 31 2015)




Financial Statements
Mateon Therapeutics Inc's Equity $ 16 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Total Liabilities $ 8 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Leverage RatioJun 30 2020 MRQ Total LiabilitiesJun 30 2020 MRQ Equity
Sunwin Stevia International Inc   1.41 $ 16.089  Millions$ 11.447  Millions
Cellular Biomedicine Group Inc   1.38 $ 45.036  Millions$ 32.533  Millions
Predictive Oncology Inc   1.35 $ 15.805  Millions$ 11.691  Millions
Biogen Inc   1.26 $ 14,203.100  Millions$ 11,289.200  Millions
Merus N v   1.23 $ 123.365  Millions$ 100.296  Millions
Royalty Pharma Plc  1.22 $ 11,416.814  Millions$ 9,394.961  Millions
Cel sci Corporation  1.21 $ 23.020  Millions$ 19.015  Millions
Aptevo Therapeutics Inc   1.14 $ 9.859  Millions$ 8.650  Millions
Sun Biopharma Inc   1.08 $ 1.722  Millions$ 1.600  Millions
Emergent Biosolutions Inc   1.03 $ 1,234.600  Millions$ 1,198.800  Millions
Soligenix Inc   1.02 $ 6.176  Millions$ 6.031  Millions
Eloxx Pharmaceuticals Inc   0.97 $ 19.630  Millions$ 20.291  Millions
Brainstorm Cell Therapeutics inc   0.96 $ 9.399  Millions$ 9.822  Millions
Oncternal Therapeutics Inc   0.96 $ 9.184  Millions$ 9.598  Millions
Chromadex Corporation  0.95 $ 20.411  Millions$ 21.581  Millions
Obalon Therapeutics Inc  0.93 $ 6.695  Millions$ 7.178  Millions
Neurocrine Biosciences Inc   0.82 $ 684.400  Millions$ 831.200  Millions
Cyanotech Corp  0.82 $ 13.103  Millions$ 15.989  Millions
Acasti Pharma Inc   0.82 $ 9.027  Millions$ 11.036  Millions
Livongo Health Inc   0.81 $ 471.163  Millions$ 578.124  Millions
Berkeley Lights Inc   0.81 $ 53.373  Millions$ 66.045  Millions
Meridian Bioscience Inc  0.80 $ 186.452  Millions$ 233.335  Millions
Immunomedics Inc   0.78 $ 462.410  Millions$ 592.227  Millions
Cidara Therapeutics Inc   0.78 $ 32.051  Millions$ 41.352  Millions
Cohbar Inc   0.76 $ 5.907  Millions$ 7.736  Millions
Sangamo Therapeutics Inc   0.75 $ 383.202  Millions$ 511.206  Millions
Eiger Biopharmaceuticals Inc   0.74 $ 43.094  Millions$ 58.491  Millions
Q Biomed Inc   0.72 $ 1.516  Millions$ 2.113  Millions
Aclaris Therapeutics Inc   0.71 $ 35.084  Millions$ 49.366  Millions
Voyager Therapeutics Inc   0.70 $ 53.804  Millions$ 76.884  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

THMO's Profile

Stock Price

THMO's Financials

Business Description

Fundamentals

Charts & Quotes

THMO's News

Suppliers

THMO's Competitors

Customers & Markets

Economic Indicators

THMO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071